Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Ulrik Fredrik Malt is active.

Publication


Featured researches published by Ulrik Fredrik Malt.


British Journal of Obstetrics and Gynaecology | 2002

Comparative levels of psychological distress, stress symptoms, depression and anxiety after childbirth—a prospective population-based study of mothers and fathers

Hans Skari; Marianne Skreden; Ulrik Fredrik Malt; Merethe Dalholt; Anniken B. Østensen; Thore Egeland; Ragnhild Emblem

Objective To compare maternal and paternal psychological responses following birth of a healthy baby; and to explore predictors of parental psychological distress.


Breast Cancer Research and Treatment | 1998

Posttraumatic distress symptoms in operable breast cancer III: Status one year after surgery

Lars Tjemsland; Jon Arne Søreide; Ulrik Fredrik Malt

One hundred and six patients with operable breast cancer were studied at intervals one day before surgery, and at six weeks and one year post-operatively by means of taped clinical interviews and self-report questionnaires (Impact of Event Scale (IES) and General Health Questionnaire (GHQ-28)). A year after surgery, 9%reported a high level of intrusive symptoms and 10% of avoidance symptoms compared to 18% and 14% after six weeks, respectively. Based on questionnaire data, a year after surgery, thirteen patients (12%) were estimated to have a posttraumatic stress disorder (PTSD) compared to fifteen patients (14%) after six weeks. Severity of posttraumatic stress symptoms (PTSS) after one year was significantly associated with impaired psychosocial functioning over the last year previous to surgery (p < 0.05), negative life events during the year before surgery (p < 0.05), health problems during the previous ten years (p < 0.01), and a personality trait characterized by high emotional reactivity (p < 0.001). Crisis support in the acute situation, type of surgery, axillary-node metastases, and postoperative adjuvant chemotherapy did not predict subsequent PTSS. Premorbid health variables, personality, and level of distress six weeks after surgery were most important risk factors for persistent PTSS in our patients with operable breast cancer stage I and II.


Journal of Affective Disorders | 2010

Symptoms and signs of the initial prodrome of bipolar disorder: A systematic review

Dag V. Skjelstad; Ulrik Fredrik Malt; Arne Holte

BACKGROUND Systematic studies addressing symptoms, signs and temporal aspects of initial bipolar prodrome are reviewed to identify potential clinical targets for early intervention. METHODS The databases PsycINFO, PubMed, EMBASE and British Nursing Index were searched for original studies. RESULTS Eight studies were identified. Irritability and aggressiveness, sleep disturbances, depression and mania symptoms/signs, hyperactivity, anxiety, and mood swings are clusters representing common symptoms and signs of the distal prodrome of bipolar disorder (BD). As time to full BD onset decreases, symptoms of mania and depression seem to increase gradually in strength and prevalence. The specificity of prodromal symptoms and signs appears to be low. Not every person who develops BD experiences a prolonged initial prodrome to the full illness. Current data on the mean duration of the prodrome are contradictory, ranging from 1.8 to 7.3 years. No qualitative studies were found. LIMITATIONS Because of the scarcity of data, studies that did not explicitly investigate bipolar prodrome were included when thematically relevant. The selected studies are methodologically diverse and the validity of some findings is questionable. Findings must be interpreted cautiously. CONCLUSIONS The initial prodrome of BD is characterized by dysregulation of mood and energy. Because of the apparently low specificity of prodromal symptoms and signs of BD, it is currently neither possible nor advisable to predict the development of BD based solely on early phenomenology. More well-designed in-depth studies, including qualitative ones, are needed to characterize the initial bipolar prodrome.


General Hospital Psychiatry | 2001

Consultation-liaison psychiatric service delivery: results from a European study

Frits J. Huyse; Thomas Herzog; Antonio Lobo; Ulrik Fredrik Malt; Brent C. Opmeer; Barbara Stein; Peter de Jonge; Richard van Dijck; Francis Creed; María Dolores Crespo; Graça Cardoso; Raoul Guimaraes-Lopes; Richard Mayou; Myriam Van Moffaert; M. Rigatelli; Paul N. Sakkas; Pekka Tienari

The reported findings of the European Consultation-Liaison Workgroup (ECLW) Collaborative Study describe consultation-liaison service delivery by 56 services from 11 European countries aggregated on a C-L service level. During the period of 1 year (1991), the participants applied a standardized, reliability tested method of patient data collection, and data were collected describing pertinent characteristics of the hospital, the C-L service, and the participating consultants. The consultation rate of 1% (median; 1.4% mean) underscores the discrepancy between epidemiology and the services delivered. The core function of C-L services in general hospitals is a quick, comprehensive emergency psychiatric function. Reasons to see patients were the following. deliberate self-harm (17%), substance abuse (7.2%), current psychiatric symptoms (38.6%), and unexplained physical complaints (18.6%) (all means). A significant number of patients are old and seriously ill. Mood disorders and organic mental disorders are most predominant (17.7%). Somatoform and dissociative disorders together constitute 7.5%. C-L services in European countries are mainly emergency psychiatric services and perform an important bridge function between primary, general health, and mental health care.


Scandinavian Journal of Gastroenterology | 1996

A New Pharmacologic Treatment of Functional Gastrointestinal Disorder: A Double-Blind Placebo-Controlled Study with Mianserin

L. Tanum; Ulrik Fredrik Malt

BACKGROUND The efficacy of unselected monoamine reuptake inhibitors (tricyclic antidepressants) in the treatment of patients with functional gastrointestinal disorders (FGD) has not been convincingly demonstrated. We investigated the efficacy of an antidepressant (mianserin) with a different receptor profile (combined 5-hydroxytryptamine-2 + 3 and alpha-2 antagonist) in FGD. METHODS After excluding patients with psychopathology and initial placebo responders from the study, eligible patients (n = 49) were randomized to 7 weeks of double-blind treatment with either mianserin, 120 mg/day, or placebo. Efficacy was assessed by using observer-completed ratings, the Global Improvement Scale, and patient self-ratings, Visual Analog Scale, and Disability Scales. RESULTS Patients taking mianserin reported less abdominal pain, symptoms of abdominal distress, and functional disability than those given placebo (p < 0.001). The efficacy was significant across different lengths of illness periods and types of functional disorder. There was no major change 4 weeks after tapering. CONCLUSION Mianserin may be an effective and well-tolerated pharmacologic short-term treatment for functional gastrointestinal disorders in patients with no clinical evidence of psychopathology.


Molecular Psychiatry | 2016

Subcortical volumetric abnormalities in bipolar disorder.

Derrek P. Hibar; Lars T. Westlye; T G M van Erp; Jerod Rasmussen; Cassandra D. Leonardo; Joshua Faskowitz; Unn K. Haukvik; Cecilie B. Hartberg; Nhat Trung Doan; Ingrid Agartz; Anders M. Dale; Oliver Gruber; Bernd Krämer; Sarah Trost; Benny Liberg; Christoph Abé; C J Ekman; Martin Ingvar; Mikael Landén; Scott C. Fears; Nelson B. Freimer; Carrie E. Bearden; Emma Sprooten; David C. Glahn; Godfrey D. Pearlson; Louise Emsell; Joanne Kenney; C. Scanlon; Colm McDonald; Dara M. Cannon

Considerable uncertainty exists about the defining brain changes associated with bipolar disorder (BD). Understanding and quantifying the sources of uncertainty can help generate novel clinical hypotheses about etiology and assist in the development of biomarkers for indexing disease progression and prognosis. Here we were interested in quantifying case–control differences in intracranial volume (ICV) and each of eight subcortical brain measures: nucleus accumbens, amygdala, caudate, hippocampus, globus pallidus, putamen, thalamus, lateral ventricles. In a large study of 1710 BD patients and 2594 healthy controls, we found consistent volumetric reductions in BD patients for mean hippocampus (Cohen’s d=−0.232; P=3.50 × 10−7) and thalamus (d=−0.148; P=4.27 × 10−3) and enlarged lateral ventricles (d=−0.260; P=3.93 × 10−5) in patients. No significant effect of age at illness onset was detected. Stratifying patients based on clinical subtype (BD type I or type II) revealed that BDI patients had significantly larger lateral ventricles and smaller hippocampus and amygdala than controls. However, when comparing BDI and BDII patients directly, we did not detect any significant differences in brain volume. This likely represents similar etiology between BD subtype classifications. Exploratory analyses revealed significantly larger thalamic volumes in patients taking lithium compared with patients not taking lithium. We detected no significant differences between BDII patients and controls in the largest such comparison to date. Findings in this study should be interpreted with caution and with careful consideration of the limitations inherent to meta-analyzed neuroimaging comparisons.


Journal of Affective Disorders | 2011

The load of short telomeres is increased and associated with lifetime number of depressive episodes in bipolar II disorder

Torbjørn Elvsåshagen; Elsa Vera; Erlend Bøen; Jorunn Bratlie; Ole A. Andreassen; D. Josefsen; Ulrik Fredrik Malt; Maria A. Blasco; Birgitte Boye

BACKGROUND It has recently been hypothesized that bipolar disorders are associated with accelerated aging. Telomere dysfunction, a biomarker of aging, is determined by the load of short telomeres, rather than by the mean telomere length. To our knowledge, the load of short telomeres has not been reported in any psychiatric disorder. The aims of the study were to examine the load of short telomeres and the mean telomere length and their relationships with illness duration and lifetime number of depressive episodes in bipolar II disorder (BD-II). METHODS Twenty-eight patients (mean age=34.8 ± 7.7) with a DSM-IV diagnosis of BD-II and 28 healthy control subjects (mean age=34.8 ± 9.2) matched for age, sex, and education participated. The load of short telomeres (percentage of telomeres <3 kilobases) and mean telomere length in peripheral blood mononuclear cells were measured using high-throughput quantitative fluorescence in situ hybridization. RESULTS The load of short telomeres was significantly increased in patients with BD-II relative to healthy controls and may represent 13 years of accelerated aging. The load of short telomeres and the mean telomere length were associated with lifetime number of depressive episodes, but not with illness duration. LIMITATIONS Modest sample size and cross-sectional design. CONCLUSIONS Our results suggest that BD-II is associated with an increased load of short telomeres. Depressive episode-related stress may accelerate telomere shortening and aging. However, longitudinal studies are needed to fully clarify telomere shortening and its relationship with clinical variables in BD-II.


Acta Psychiatrica Scandinavica | 1989

A long-term psychosocial follow-up study of burned adults

Ulrik Fredrik Malt; O. M. Ugland

ABSTRACT A clinical psychiatric follow‐up study of 70 burned adults was performed 3–13 years after the burn injury. The majority of patients had minor injuries. Twenty‐three percent suffered from definite psychosocial problems at follow up. Patients with severe injuries more often had problems (44%) than patients with minor injuries (16%). Outcome was not related to premorbid psychopathology except for patients with more severe injuries. A combination of variables describing length of hospital stay, the presence of scars, premorbid psychopathology, experiencing death threat when injured and deviant behaviour during the hospital stay was found to be the best predictor of negative psychosocial outcome (positive predicting power 83%; sensitivity 94%).


Psychosomatic Medicine | 1997

Physical and Mental Problems Attributed to Dental Amalgam Fillings: A Descriptive Study of 99 Self-referred Patients Compared with 272 Controls

Ulrik Fredrik Malt; Per Nerdrum; Bjørn Oppedal; Roger Gundersen; Martin Holte; Jostein Löne

Objective The physical and mental symptomatology of 99 self-referred patients complaining of multiple somatic and mental symptoms attributed to dental amalgam fillings were compared with patients with known chronic medical disorders seen in alternative (N = 93) and ordinary (N = 99) medical family practices and patients with dental amalgam fillings (N = 80) seen in an ordinary dental practice. Method The assessments included written self-reports, a 131-item somatic symptom checklist; Eysenck Personality Questionnaire, the General Health Questionnaire, and Toronto Alexithymia Scale. Results The dental amalgam sample reported significantly more physical symptoms from all body regions. Self-reports suggested that 62% suffered from a chronic anxiety disorder (generalized anxiety disorder or panic). Forty-seven percent suffered from a major depression compared with 14% in the two clinical-comparison samples and none in the dental control sample. Symptoms suggesting somatization disorder were found in 29% of the dental amalgam sample compared with only one subject in the 272 comparison subjects. One third of the dental amalgam patients reported symptoms of chronic fatigue syndrome compared with none in the dental control sample and only 2 and 6%, respectively, in the two clinical comparison samples. The dental amalgam group reported higher mean neuroticism and lower lie scores than the comparison groups. Conclusion Self-referred patients with health complaints attributed to dental amalgam are a heterogeneous group of patients who suffer multiple symptoms and frequently have mental disorders. There is a striking similarity with the multiple chemical sensitivity syndrome.


BMJ | 1999

The Norwegian naturalistic treatment study of depression in general practice (NORDEP)—I: randomised double blind study

Ulrik Fredrik Malt; Ole Herman Robak; H-P Madsbu; O. Bakke; M. Loeb

Abstract Objective: To evaluate the efficacy of emotional support and counselling combined with placebo or antidepressants with single or dual mechanism of action in the treatment of depression in primary care. Design: Randomised double blind study. Setting: Several locations in Norway. Subjects: 372 patients with depression. Main outcome measures: Improvement (clinical remission) reported both by the patient (Montgomery Åsberg depression rating scale) and the physician (clinical global improvement and impression scales). Results: Intention to treat analyses showed 47% remission in patients randomised to placebo compared with 61% remission in patients randomised to sertraline (odds ratio 0.56, 95% confidence interval 0.33 to 0.96) and 54% in patients randomised to mianserin (0.75, 0.44 to 1.27). Women responded better than men (1.86, 1.17 to 2.96). Subgroup analyses showed that subjects with recurrent depression (n=273) responded more frequently to sertraline than to placebo (0.43, 0.23 to 0.82) than those having their first episode of depression (1.18, 0.39 to 3.61). Statistically significant interactions between type of drug treatment and history of depression were not shown by logistic regression. Conclusion: The combination of active drug and simple psychological treatment (counselling, emotional support, and close follow up over a 24 week period) was more effective than simple psychological treatment alone, in particular for those with recurrent depression. Overall, women may benefit more than men. If confirmed in future studies, the findings should lead to more differentiated treatment guidelines for depression in primary care.

Collaboration


Dive into the Ulrik Fredrik Malt's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Birgitte Boye

Oslo University Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Arne E. Vaaler

Norwegian University of Science and Technology

View shared research outputs
Top Co-Authors

Avatar

Gunnar Morken

Norwegian University of Science and Technology

View shared research outputs
Top Co-Authors

Avatar

Guttorm Haugen

Oslo University Hospital

View shared research outputs
Top Co-Authors

Avatar

Erlend Bøen

Oslo University Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge